References:
1. Dor O, Haim M, Barrett O, Novack V, Konstantino Y. Incidence and
Clinical Outcomes of Pacing Induced Cardiomyopathy in Patients With
Normal Left Ventricular Systolic Function and Atrioventricular Block. Am
J Cardiol 2020;128 :174-80 doi: 10.1016/j.amjcard.2020.05.017
[published Online First: 20200518].
2. Cho SW, Gwag HB, Hwang JK, et al. Clinical features, predictors, and
long-term prognosis of pacing-induced cardiomyopathy. Eur J Heart Fail
2019;21 (5):643-51 doi: 10.1002/ejhf.1427 [published Online
First: 20190208].
3. Somma V, Ha FJ, Palmer S, Mohamed U, Agarwal S. Pacing-induced
cardiomyopathy: A systematic review and meta-analysis of definition,
prevalence, risk factors, and management. Heart Rhythm
2023;20 (2):282-90 doi: 10.1016/j.hrthm.2022.09.019 [published
Online First: 20221107].
4. Merchant FM, Mittal S. Pacing induced cardiomyopathy. J Cardiovasc
Electrophysiol 2020;31 (1):286-92 doi: 10.1111/jce.14277
[published Online First: 20191125].
5. Sanchez R, Nadkarni A, Buck B, et al. Incidence of pacing-induced
cardiomyopathy in pacemaker-dependent patients is lower with leadless
pacemakers compared to transvenous pacemakers. J Cardiovasc
Electrophysiol 2021;32 (2):477-83 doi: 10.1111/jce.14814
[published Online First: 20201125].
6. Al-Bawardy R, Krishnaswamy A, Bhargava M, et al. Tricuspid
regurgitation in patients with pacemakers and implantable cardiac
defibrillators: a comprehensive review. Clin Cardiol
2013;36 (5):249-54 doi: 10.1002/clc.22104 [published Online
First: 20130325].
7. Kim JB, Spevack DM, Tunick PA, et al. The effect of transvenous
pacemaker and implantable cardioverter defibrillator lead placement on
tricuspid valve function: an observational study. J Am Soc Echocardiogr
2008;21 (3):284-7 doi: 10.1016/j.echo.2007.05.022 [published
Online First: 20070702].
8. Klutstein M, Balkin J, Butnaru A, Ilan M, Lahad A, Rosenmann D.
Tricuspid incompetence following permanent pacemaker implantation.
Pacing Clin Electrophysiol 2009;32 Suppl 1 :S135-7 doi:
10.1111/j.1540-8159.2008.02269.x.
9. Beurskens NEG, Tjong FVY, de Bruin-Bon RHA, et al. Impact of Leadless
Pacemaker Therapy on Cardiac and Atrioventricular Valve Function Through
12 Months of Follow-Up. Circ Arrhythm Electrophysiol
2019;12 (5):e007124 doi: 10.1161/CIRCEP.118.007124.
10. Merchant FM. Pacing-induced cardiomyopathy: just the tip of the
iceberg? Eur Heart J 2019;40 (44):3649-50 doi:
10.1093/eurheartj/ehz715.
11. Jastrzebski M. ECG and Pacing Criteria for Differentiating
Conduction System Pacing from Myocardial Pacing. Arrhythm Electrophysiol
Rev 2021;10 (3):172-80 doi: 10.15420/aer.2021.26.
12. Zhang XH, Chen H, Siu CW, et al. New-onset heart failure after
permanent right ventricular apical pacing in patients with acquired
high-grade atrioventricular block and normal left ventricular function.
J Cardiovasc Electrophysiol 2008;19 (2):136-41 doi:
10.1111/j.1540-8167.2007.01014.x [published Online First: 20071112].
13. Victor F, Mabo P, Mansour H, et al. A randomized comparison of
permanent septal versus apical right ventricular pacing: short-term
results. J Cardiovasc Electrophysiol 2006;17 (3):238-42 doi:
10.1111/j.1540-8167.2006.00358.x.
14. Bansal R, Parakh N, Gupta A, et al. Incidence and predictors of
pacemaker-induced cardiomyopathy with comparison between apical and
non-apical right ventricular pacing sites. J Interv Card Electrophysiol
2019;56 (1):63-70 doi: 10.1007/s10840-019-00602-2 [published
Online First: 20190730].
15. Hai JJ, Mao Y, Zhen Z, et al. Close Proximity of Leadless Pacemaker
to Tricuspid Annulus Predicts Worse Tricuspid Regurgitation Following
Septal Implantation. Circ Arrhythm Electrophysiol
2021;14 (5):e009530 doi: 10.1161/CIRCEP.120.009530 [published
Online First: 20210517].
16. Salaun E, Tovmassian L, Simonnet B, et al. Right ventricular and
tricuspid valve function in patients chronically implanted with leadless
pacemakers. Europace 2018;20 (5):823-28 doi:
10.1093/europace/eux101.